Company Filing History:
Years Active: 2009
Title: Hsiang-Ru Lin: Innovator in Anti-Estrogenic and Anti-Androgenic Compounds
Introduction
Hsiang-Ru Lin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target estrogen and androgen receptors. His work is crucial for advancing treatments for various hormone-related diseases.
Latest Patents
Hsiang-Ru Lin holds a patent for "Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases." This patent includes compounds that are tetrahydroquinoline phenylamide derivatives, which are useful for treating breast and prostate cancer, as well as osteoporosis. His innovative approach provides new avenues for addressing estrogen-receptor related maladies.
Career Highlights
Hsiang-Ru Lin is affiliated with Virginia Commonwealth University, where he continues to engage in research and development. His academic background and ongoing research efforts contribute to the advancement of therapeutic options in oncology and endocrinology.
Collaborations
Some of his notable coworkers include Richmond E Danso-Danquah and Donald J Abraham. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Hsiang-Ru Lin's work in developing anti-estrogenic and anti-androgenic compounds represents a significant advancement in medical science. His contributions are vital for improving treatment options for hormone-related diseases.